Načítá se...
Protection from Genital Herpes Disease, Seroconversion, and Latent Infection in a Non-lethal Murine Genital Infection Model by Immunization with an HSV-2 Replication-Defective Mutant Virus
Viral vaccines have traditionally protected against disease, but for viruses that establish latent infection, it is desirable for the vaccine to reduce infection to reduce latent infection and reactivation. While seroconversion has been used in clinical trials of herpes simplex virus (HSV) vaccines...
Uloženo v:
| Vydáno v: | Virology |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744556/ https://ncbi.nlm.nih.gov/pubmed/26609935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2015.10.033 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|